IBCD Activities

This page describes the proposed activities of the now disbanded International Biopesticide Consortium for Development (IBCD). It has been retained here to provide inspiration for future activities of the SIP Microbial Control Division. All suggestions will be most welcome ...

Activity

Target audience

Training

Screening, isolation, identification
Production, formulation, storage
Registration, safety procedures
Ecology and use strategies
Development and commercialisation

 

Researchers at universities, national research institutes

Workshops

Harmonisation of regulatory framework
Benefits of biopesticides
Training, education and extension needs

 

Regulatory, environmental, and research policy-makers. SME community

Information Dissemination

Electronic knowledge/learning networks
Research reports
Training manuals
Policy papers and briefings
Newsletter

 

Researchers, policy-makers, end-users, SME community, donors, general public

Small Project Assistance

Operational funding, with preference for projects that lead to development of biopesticide products
Maximum of £200,000 per year allocated (minimum of 10 grants per year)

 

Researchers at universities, national research institutes

Small Equipment Assistance

Purchase of equipment whose absence limits progress of research
Maximum of £100,000 per year allocated

 

Researchers at universities, national research institutes

Support for Toxicology Testing

To ensure that all potential products meet international standards of safety
Results published in the public domain

 

Universities, research institutes, companies

 

The three case studies described below represent real-life, biopesticide projects that are currently in varying stages of development – from the early stages of research, to the onset of commercial use. These examples illustrate the wide range of barriers to utilisation that biopesticide projects are likely to encounter. In each case, IBCD activities in the form of training, consultation, and financial and strategic support could result in increased utilisation of biopesticides in a safe, sustainable and beneficial manner.

Case Study I: Banana weevil, Cosmopolites sordidus

A Research-Driven Project

Occurrence

Tropical regions of the world where bananas are grown, including Africa, South America, Australia and South Pacific islands, Southeast Asia, West Indies, tropical U.S. (Hawaii and Florida)

Biopesticide candidate

Beauveria bassiana

Problems addressed by biopesticide

High toxicity of recommended insecticides (carbofuran, chlorpyrifos, fenamiphos)
Resistance to recommended insecticides
Insecticide toxicity and cost makes them inappropriate for resource poor farmers

Institutions involved

Kawanda Agricultural Research Institute, Uganda
International Institute of Tropical Agriculture, Benin

Development status

Phase 1 and 2 scientific goals completed, small-scale production process and candidate formulation identified

Immediate barriers to development

Mammalian safety, worker handling procedures uncharacterised
No intellectual property strategy
Limited or no awareness among regulatory officials, key decision-makers
Use patterns (rate, frequency of application, etc) and performance expectations (minimum efficacy levels, formulation preferences, storage requirements, etc) not determined
Target market (geographic, socioeconomic) not defined

Case Study II: Potato tubermoth, Phthorimaea operculella

An End User-Driven Project

Occurrence

Tropical, potato growing regions in India, the Philippines, Thailand, North Africa, Peru and the Middle East

Biopesticide candidate

Baculovirus phthorimaea (granulosis virus)

Problems addressed by biopesticide

Unavailability of registered insecticides for this use
Need for safe products, due to proximity of potato storage to housing
Insecticide toxicity and cost makes them inappropriate for resource poor farmers

Institutions involved

International Potato Center, Peru

Development status

Majority of Phase 1 – 3 scientific, development, manufacturing and economics goals accomplished

Immediate barriers to development

Mammalian safety, worker handling procedures uncharacterised
Storage stability not determined
Business/marketing/distribution plan not developed
No intellectual property strategy

Case Study III: Maize stem borer complex

A Commercially-Driven Project

Pests:

Busseola fusca, Sesamia calamistis, Eldana saccharina, Chilo partellus

Occurrence

Africa

Biopesticide candidate

Commercial products based on Bacillus thuringiensis var. kurstaki. (e.g. Javelin, Dipel)

Problems addressed by biopesticide

High toxicity of recommended insecticides (carbofuran, carbaryl)
Insecticide toxicity and cost makes them inappropriate for resource poor farmers

Institutions involved (potentially)

Abbott Labs
ThermoTrilogy

Development status

Phase 1 –4 regulatory and manufacturing goals completed by commercial companies; efficacy established on related pests

Immediate barriers to development

Efficacy tests to determine use patterns under local conditions not completed
African research institute not yet involved
Donor support for product purchase probably required

 

Target Geography

IBCD activities will be focused in five regions:

Africa
Asia
Central and South America
Eastern Europe
Middle East

Analysis of the biopesticide development capabilities in these regions indicates two definable situations:

Embryonic biopesticide development capability: poor or non-existent research expertise or infrastructure, few or no biopesticide enterprises. Examples include Angola, Benin, Botswana, Chad, Gambia, Ghana, Cote d’Ivoire, Togo, Tanzania, Zambia, Zaire, Mali, Mauritania, Mozambique, Madagascar, Eritrea, Ethiopia, Senegal, and Sudan.
Existing biopesticide development capability: existing R&D base, dedicated laboratories, an existing biopesticide industry (usually cottage, low to intermediate technology). Examples include: Argentina, Brazil, China, Columbia, Egypt, India, Kenya, Korea, Morocco, Philippines, South Africa, Vietnam, Zimbabwe.

IBCD will provide service to countries in both categories, with the recognition that each face different constraints and problems based on their specific level of exisiting biopesticide development.

 

[home]  [members] [flow chart] [reports] [biopesticides] [activities] [regulatory] [links]

Please direct questions about this web page to:

E Mail: webmaster